Document is current
Any future updates will be listed below
-
Authors
Vermeulen, Michael
Craig, Andrew W.
Babak, Tomas
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research Project Grant (PJT 178214)
Canadian Institutes of Health Research Project Grant (PJT 178214)
- License Information
-
More Information
Article History
Received: 22 April 2025
Accepted: 1 November 2025
First Online: 13 December 2025
Competing interests
: T.B. is the founder and CSO of Leapfrog Bio Inc. and is the majority shareholder. All authors declare no non-financial competing interests.
